Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 21, 2026; 32(47): 123905
Published online Dec 21, 2026. doi: 10.3748/wjg.123905
Published online Dec 21, 2026. doi: 10.3748/wjg.123905
Figure 6 Forest plot comparing the risk of hepatocellular carcinoma between patients with chronic hepatitis B alone and those with chronic hepatitis B and metabolic dysfunction-associated fatty liver disease.
Pooled effects are expressed as odds ratios with 95%CIs. MAFLD: Metabolic dysfunction-associated fatty liver disease; CHB: Chronic hepatitis B.
- Citation: Liu J, Zhang P, Hu KZ, Zhao ZH, Xin YN, Bi YZ. Metabolic dysfunction-associated fatty liver and antiviral response in chronic hepatitis B: A systematic review and meta-analysis. World J Gastroenterol 2026; 32(47): 123905
- URL: https://www.wjgnet.com/1007-9327/full/v32/i47/123905.htm
- DOI: https://dx.doi.org/10.3748/wjg.123905